Die gliedergürtelmuskeldystrophie vom typ 21 - Ein neues, klinisch heterogenes krankheitsbild

Translated title of the contribution: The limb-girdle muscular dystrophy type 21 - A new, clinically heterogeneous disease

Michael Krasnianski, S. Neudecker, M. Deschauer

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The autosomal recessive inherited LGMD2I is caused by mutations in the fukutin-related protein (FKRP) gene. In majority of european patients the common C826A mutation can be identified. The variable clinical course is ranging from severe, rapid progressive disease with weakness and wasting of the shoulder-girdle muscles and proximal extremities, and calf hypertrophy to mild disorder. Occasionally, the disease is limited to myalgia, cardiomyopathy or elevated serum of creatine kinase (CK) without clear muscular weakness. The electrophysiological and histological investigations in this disease are not specific, and the diagnosis of the LGMD2I is based on molecular identification of a typical mutation in the FKRP gene. Because of the extreme variety of clinical phenotypes in patients with LGMD2I, this disease should be considered not only in limb-girdle syndromes, but also in patients with myalgia, cardiomyopathy, and elevated serum CK.

Translated title of the contributionThe limb-girdle muscular dystrophy type 21 - A new, clinically heterogeneous disease
Original languageGerman
Pages (from-to)438-441
Number of pages4
JournalNervenheilkunde
Volume23
Issue number8
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'The limb-girdle muscular dystrophy type 21 - A new, clinically heterogeneous disease'. Together they form a unique fingerprint.

Cite this